CFR Presents

Asia Unbound

CFR experts give their take on the cutting-edge issues emerging in Asia today.

Posts by Category

Showing posts for "Innovation"

Podcast: The Paper Tigers and Hidden Dragons of China’s Tech Sector

by Elizabeth C. Economy
Paper-Tigers-Hidden-Dragons-2

Chinese President Xi Jinping has claimed that the direction of China’s technological development is “innovation, innovation and more innovation.” But besides prominent success stories like Huawei and Lenovo, how innovative are other companies in China’s tech sector? In this week’s Asia Unbound podcast I talk with Douglas Fuller, professor of business administration at Zhejiang University’s School of Management, about his upcoming book—possibly the best China book I have read all year—Paper Tigers, Hidden Dragons: Firms and the Political Economy of China’s Technological Development. Read more »

Off-Label Use of Drugs and Access to Medicines for All: A Thailand Example

by Yanzhong Huang
A worker makes his way on a bridge at Swiss pharmaceutical company Roche plant. Roche is the manufacturer of Avastin, a cancer medication used for off-label treatment for macular disease in place of the more expensive Lucentis. (Christian Hartmann/Reuters) A worker makes his way on a bridge at Swiss pharmaceutical company Roche plant. Roche is the manufacturer of Avastin, a cancer medication used for off-label treatment for macular disease in place of the more expensive Lucentis. (Christian Hartmann/Reuters)

Several years ago an Indonesian girl named Widya posted a message on my blog. She asked where she could obtain the drug Sorafenib for her father, who was terminally ill with liver cancer. Her family had already spent a significant sum on her father’s healthcare and could not afford further treatment. I forwarded the message to a pharmaceutical executive in Jakarta, who responded that Sorafenib was available in Indonesia but a month’s dosage would cost around $4,500 (the average monthly salary in Jakarta is about $1,180). “I hope the patient has health insurance coverage, otherwise the family will have to pay out of pocket,” he said.

Read more »

U.S. Assessments of North Korean Missile Capabilities Since 2011

by Scott A. Snyder
Missiles are taken on trucks past a stand with North Korean leader Kim Jong Un during the parade celebrating the 70th anniversary of the founding of the ruling Workers' Party of Korea, in Pyongyang October 10, 2015. Isolated North Korea marked the 70th anniversary of its ruling Workers' Party on Saturday with a massive military parade overseen by leader Kim Jong Un, who said his country was ready to fight any war waged by the United States. (Courtesy REUTERS/James Pearson) Missiles are taken on trucks past a stand with North Korean leader Kim Jong Un during the parade celebrating the 70th anniversary of the founding of the ruling Workers' Party of Korea, in Pyongyang October 10, 2015. Isolated North Korea marked the 70th anniversary of its ruling Workers' Party on Saturday with a massive military parade overseen by leader Kim Jong Un, who said his country was ready to fight any war waged by the United States. (Courtesy REUTERS/James Pearson)

The Democratic People’s Republic of Korea (DPRK or North Korea) announced that it successfully launched the Kwangmyongsong-4 satellite at 9:30 am on February 7, 2016. But the United States regards DPRK satellite launches as thinly-veiled efforts to advance its long-range ballistic missile capabilities. Secretary of State John Kerry condemned the latest launch as “a flagrant violation of UN Security Council Resolutions related to the DPRK use of ballistic missile technology.” This compilation of statements by U.S. government officials over the past five years shows U.S. assessments regarding North Korea’s ballistic missile capabilities. Read more »

How Korea Can Lead on Climate Change

by Guest Blogger for Scott A. Snyder
South Korea's President Lee Myung-bak delivers a speech at an inaugural meeting of the Global Green Growth Institute (GGGI) in Seoul October 23, 2012. The Institute, launched in 2010 to promote green economic growth strategies, was upgraded last week to the status of an international organisation, reported local media. (REUTERS/Jung Yeon-je/Pool) South Korea's President Lee Myung-bak delivers a speech at an inaugural meeting of the Global Green Growth Institute (GGGI) in Seoul October 23, 2012. The Institute, launched in 2010 to promote green economic growth strategies, was upgraded last week to the status of an international organisation, reported local media. (REUTERS/Jung Yeon-je/Pool)

Note: Asia Unbound is reposting this blog today, as it was supposed to be published this week, not last week when this piece was first published.

Jill Kosch O’Donnell is an independent researcher and writer.

The global climate talks underway in Paris this week, aimed at achieving a successor treaty to the Kyoto Protocol, represent a milestone in an evolving approach to these annual UN-led negotiations. Formerly focused on haggling over developed country targets for emissions reductions, they now emphasize action by all countries, which were supposed to submit national climate change plans ahead of time, known as “intended nationally determined contributions” (INDCs). This new modus operandi presents an opening for Korea to assert itself as a middle power, drawing on its dual identity as a developing country and an OECD member. But it will not be through the country’s INDC. Read more »

Will Chinese Universities Go Global?

by Guest Blogger for Elizabeth C. Economy
A student poses for a photo after a graduation ceremony at Tsinghua University in Beijing, July 11, 2006. About 4.1 million are expected to graduate this year, an increase of 22 percent over 2005, the official Xinhua news agency reported. REUTERS/Jason Lee (CHINA) A student poses for a photo after a graduation ceremony at Tsinghua University in Beijing, July 11, 2006. (Jason Lee/Reuters)

Rachel Brown is a research associate in Asia Studies at the Council on Foreign Relations.

Amid the flurry of press coverage surrounding President Xi Jinping’s visit to the United States in September, his gift of a dawn redwood tree to be planted on the campus of the Global Innovation Exchange (GIX) program in Seattle received little attention. However, the GIX program, a collaboration between China’s prestigious Tsinghua University and the University of Washington, reflects a next step in China’s soft power strategy. Presenting a model for higher education has characterized global powers from nineteenth century Germany to the present day United States, and China now seems to be making a bid to promote its own educational model abroad. While over the past two decades, American and other foreign universities have flocked to establish campuses and centers in China, GIX will be the first outpost of a Chinese university in the United States.

Read more »

Tu Youyou: An Outlier of China’s Scientific and Technological System

by Yanzhong Huang
Tu Youyou, 84, has become the first Chinese woman to win a Nobel Prize, for her work in helping to create an anti-malaria medicine. (Flickr) Tu Youyou, 84, has become the first Chinese woman to win a Nobel Prize, for her work in helping to create an anti-malaria medicine. (Flickr)

On October 5, a native Chinese scientist, Tu Youyou, won the Nobel Prize in medicine for her role in developing an antimalarial drug that saves millions of lives in Africa and Asia. The award is considered a milestone in China’s history of science and technology as Tu is not only the first Chinese citizen but also the first Chinese-trained scientist ever to be awarded the most prestigious award in science. In fact, unlike other Chinese Nobel laureates in science, all of whom had overseas training, Tu had neither study nor research experience abroad. The most important research that led to the discovery of the medicine for which she was awarded the prize, artemisinin, was conducted in China. Surprised but exalted, many Chinese have attributed this prize to China’s scientific and technological (S&T) regime. Already, social media in China is flooded with discussions on who will be the next Chinese scientist to win the prize. Read more »

Guest Post: Micron Takeover by Chinese Company Raises Cybersecurity and Regulatory Concerns

by Guest Blogger for Yanzhong Huang
Memory chip parts of U.S. memory chip maker MicronTechnology are pictured at their fair booth at an industrial fair in Frankfurt, Germany, July 14, 2015. China's state-backed Tsinghua Unigroup Ltd is preparing a $23 billion bid for Micron in what would be the biggest Chinese takeover of a U.S. company. (Reuters/Kai Pfaffenbach) Memory chip parts of U.S. memory chip maker MicronTechnology are pictured at their fair booth at an industrial fair in Frankfurt, Germany, July 14, 2015. China's state-backed Tsinghua Unigroup Ltd is preparing a $23 billion bid for Micron in what would be the biggest Chinese takeover of a U.S. company. (Reuters/Kai Pfaffenbach)

by Ariella Rotenberg and Peng Di

Ariella Rotenberg is a research associate in U.S. foreign policy at the Council on Foreign Relations. Peng Di, a former intern for the global health program, also contributed to this post.

Just this week, the Obama administration announced publicly that it would retaliate against China for coordinating a cyber attack that resulted in the theft of over twenty million American’s personal information. While attention in the public sphere is currently focused on the administration’s policy reversal, over the course of the past few weeks many technology fiends, finance experts, and cybersecurity analysts turned their attention to the potential buyout of the Boise, Idaho-based Micron Technology Inc. by Chinese company Tsinghua Unigroup. Read more »

Guest Post: With the Gaokao, Hacking and Drones Are Just a Way to Get Ahead

by Guest Blogger for Adam Segal
A police officer displays a pair of glasses (R) with a hidden camera and a tiny receiver attached to a coin, which are both exam cheating equipment confiscated by the police, in Shenyang, Liaoning province November 22, 2013. Chinese authorities vowed harsh treatment for organizing or helping cheating in the national college entrance exam, which took place on June 7 and 8 this year. Education and police authorities will continue to investigate crimes including stealing and selling examination papers, leaking information to exam sitters, providing equipment designed for cheating, and cyber attacks on exam websites. The Ministry of Education warned that cheating students would be stripped of the enrollment qualification for a period ranging from one to three years, Xinhua News Agency reported. Picture taken November 22, 2013. REUTERS/Stringer (CHINA - Tags: EDUCATION CRIME LAW SOCIETY) CHINA OUT. NO COMMERCIAL OR EDITORIAL SALES IN CHINA A police officer displays a pair of glasses (R) with a hidden camera and a tiny receiver attached to a coin, which are both exam cheating equipment confiscated by the police, in Shenyang, Liaoning province, on November 22, 2013 (Stringer/Reuters).

By Lincoln Davidson

Lincoln Davidson is a research associate for Asia studies at the Council on Foreign Relations.

Each year, millions of Chinese high school graduates take a two-day college entrance examination, colloquially known as the gaokao, that determines whether they’ll be able to attend university. The nine-hour test—which covers history, English, calculus, physics, chemistry, political theory, and more—is highly competitive, and students in the past have resorted to stolen questions and even IV drips to help them prepare. But as this year’s exam approaches, the test’s high stakes are pushing some to resort to technological means to give their score a boost. Read more »

Rotenberg and Di: Ali Health Offers a Revolutionary Moment for China’s Healthcare Industry

by Guest Blogger for Yanzhong Huang
Alibaba Group Holding Ltd chairman Jack Ma gestures during a talk by Our Hong Kong Foundation in Hong Kong, February 2, 2015. The head of China's commerce regulator met with Alibaba Group Holding Ltd chairman Jack Ma last Friday to discuss combating fake products, the official Xinhua news agency reported, with the two adopting a conciliatory tone after a row over illegal business on the Internet company's platforms. (Bobby Yip/Courtesy Reuters) Alibaba Group Holding Ltd chairman Jack Ma gestures during a talk by Our Hong Kong Foundation in Hong Kong, February 2, 2015. The head of China's commerce regulator met with Alibaba Group Holding Ltd chairman Jack Ma last Friday to discuss combating fake products, the official Xinhua news agency reported, with the two adopting a conciliatory tone after a row over illegal business on the Internet company's platforms. (Bobby Yip/Courtesy Reuters)

Ariella Rotenberg is a research associate for U.S. Foreign Policy, and Peng Di is an intern for Global Health Governance at the Council on Foreign Relations.

Private sector actors in China, first and foremost Alibaba, are taking significant steps to do what they believe will earn a handsome profit in the growing Chinese healthcare industry. With a market estimated to reach one trillion dollars by 2020, companies are working fast to secure their slice of the expanding Chinese healthcare pie. Read more »

Artemisinin’s Rocky Road to Globalization: Part II

by Yanzhong Huang
A health worker checks a blood sample for malaria in the only hospital in Pailin in western Cambodia January 28, 2010. Bordering with Thailand, this former Khmer Rouge stronghold and dusty gem mining town is now better known for a malarial parasite that is worrying health experts in the region. Studies and research show artemisinin-based therapies - currently the most effective treatment against malaria - are taking longer to cure some of the patients. (Damir Sagolj/ Courtesy: Reuters) A health worker checks a blood sample for malaria in the only hospital in Pailin in western Cambodia January 28, 2010. Bordering with Thailand, this former Khmer Rouge stronghold and dusty gem mining town is now better known for a malarial parasite that is worrying health experts in the region. Studies and research show artemisinin-based therapies - currently the most effective treatment against malaria - are taking longer to cure some of the patients. (Damir Sagolj/ Courtesy: Reuters)

In my previous blog post, I described how artemisinin-based drugs were discovered in China in the 1970s and 1980s. Given their potency for the treatment of malaria, one would expect that Chinese made artemisinin-based drugs quickly became the first choice medicine in the global fight against malaria. Much to the chagrin of Chinese scientists and pharmaceutical companies, the World Health Organization (WHO) did not list a single one of China’s antimalarial drugs on its procurement list until 2007.

Read more »